for medical use
of Senadeksin Torgovoye medicine a name
Mezhdunarodnoye the unlicensed name
Is not present
the Dosage form
of the Tablet of 70 mg
One tablet contains
active agent – Sennas of a sheet of extract dry in terms of 20% content of sennozid of calcium And yes In (the sums of sennozid of calcium A and B) 70 mg,
excipients: lactoses monohydrate, starch corn, vanillin, magnesium stearate, methylparahydroxybenzoate, stearic acid, talc.
of the Tablet of the correct round cylindrical shape, with a flat surface, from light brown till dark brown color with impregnations, with a vanillin smell, with slanted edges, with risky on one party.
Laxatives. Contact depletive. Sennas glycosides.
The ATX A06A B06 code
Pharmacokinetics Active Ingredients properties of drug (metabolites of antraglikozid of Senna) are practically not soaked up, generally removed with a stake and also with urine. Are allocated also with then, get into breast milk.
Laxative drug of plant origin (a leaf of Senna or the Alexandria leaf, or a leaf of a cassia acutifoliate) with soft action.
Pharmacological action is caused by antraglikozida (generally sennozida And yes C) and also other glycosides. At intake the glycosides of Senna pass through a stomach and a small intestine in not changed look, without being soaked up. In a large intestine of an antraglikozida are split by colibacilli on pharmacological active Anteronums and anthranols which irritate interoretseptor of a large intestine, interfere with absorption of water and electrolytes, diffusions of water in an intestines gleam promote owing to what there is a loosening of stool and increase in their volume that promotes strengthening of a vermicular movement and acceleration of bowel emptying.
Laxative action is shown in 6 – 10 h. At prolonged use of drug the intensity of its action can decrease because of reduction of content of potassium in an organism.
Drug is well transferred by patients, in connection with the small content of resinous substances does not render irritant action on intestines.
– a chronic constipation
– hypo – and an intestines atony
– simplification of bowel emptying in hemorrhoids, a proctitis and anal fissures
– purgation before the diagnostic and medical
Route of administration procedures and doses
Accept inside, once a day, washing down with liquid. To adults and children 12 years are more senior appoint before going to bed, to children 12 years – on an empty stomach are younger in the morning.
To adults and children 12 years are more senior appoint 1 – 2 tablet, in the absence of effect increase a dose to 2 – 3 tablets by reception. The maximum daily dose – 3 tablets.
To children aged from 6 up to 12 years appoint on 1 tablet. The maximum daily dose – 2 tablets.
It is necessary to accept the smallest dose necessary for receiving soft a calla. At selection of a dose it is necessary to apply the same dose within several days, in the absence of effect – gradually to increase a dose by ½ tablets. If at use of the maximum dose within three days the defecation does not happen, it is necessary to see a doctor.
At course use after two weeks of use of drug it is necessary to take a break in two weeks.
It is not necessary to accept a long time or in the doses exceeding recommended.
Doses and duration of treatment are defined individually.
– anorexia, pain in a stomach, diarrhea
– urine coloring change
– allergic reactions
Are possible (at prolonged use)
– loss of electrolytes, generally potassium ions
– an albuminuria, a hamaturia
– an intestines pseudomelanosis
– an atony of a large intestine, a meteorism, digestion disturbances.
– the increased individual sensitivity to glycosides of Senna and other components of drug
– intestinal impassability
– acute inflammatory bowel diseases (Crohn’s disease, ulcer colitis, appendicitis)
– a round ulcer of a stomach and duodenum
– gastrointestinal bleedings
– the restrained hernia
– pain in a stomach of unspecified genesis
– heavy disturbances of water and electrolytic balance
– children’s age up to 6 years
– the hereditary intolerance of fructose, deficiency of Lapp-lactases enzyme, glucose galactose malabsorption
At prolonged use or use in high doses drug enhances effect of cardiac glycosides and antiarrhytmic means in communication of decrease in maintenance of potassium ions in an organism, breaks absorption of tetracyclines. At simultaneous use with thiazide diuretics, adrenal hormones, drugs from a root of a licorice the risk of development of a hypopotassemia increases. Reduces efficiency of the drugs which are slowly soaking up in digestive tract.
Drug is recommended to be used only if normalization of a chair does not manage to be achieved change of a diet or use of the drugs increasing the volume of intestinal contents.
With care it is necessary to use drug at patients with diseases of a liver and/or kidneys.
During treatment color of urine in yellowish-brown or reddish color depending on rn urine can change.
Use in pediatrics
At children’s age is more senior than 6 years drug appoint with care, according to the recommendation of the doctor.
The period of pregnancy and a lactation
Use of drug for pregnant women is accompanied by higher probability of development of side effects (abdominal pains, diarrhea). For the period of drug treatment the feeding by a breast is recommended to be stopped since components of drug can get into breast milk and cause a frequent liquid chair in the baby.
Influence on a possibility of driving and potentially dangerous mechanisms
Drug usually does not influence a possibility of driving and performance of work, the requiring special attention, speed of mental and motor reactions. However it is necessary to consider individual reaction to drug.
Symptoms: the diarrhea leading to disturbances of water and electrolytic balance.
Treatment: symptomatic therapy.
A form of release and packing
On 10 tablets in blister strip packaging from a film polyvinylchloride and material rolled packing on the basis of aluminum foil.
Blister strip packagings together with iinstruktion on medical use in the state and Russian languages place in boxes of cardboard.
To Store storage conditions in the dry, protected from light place at a temperature not above 25 °C.
To store out of children’s reach!
not to use a period of storage after an expiration date.
JSC Lubnypharm Producer.
Ukraine, 37500, Poltava Region, Lubny, Petrovskogo St., 16.
Name and country of the owner of the registration certificate
of JSC Lubnypharm, Ukraine.
The address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods) of Pharm-Euro LLP 050039, Almaty, Mailing St., 72, apartment 34 Fax: +7 (272) 71-84-97E-mail: email@example.com